You just read:

Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products

News provided by

Jazz Pharmaceuticals plc

Aug 29, 2017, 06:30 ET